Keyphrases
Growth Factors
100%
Randomized Placebo-controlled Trial
100%
Insulin-like
100%
Human Immunodeficiency Virus Infection
100%
Growth Hormone Treatment
100%
Treatment Group
100%
RhGH
75%
Anabolic Effect
50%
Twice Daily
50%
Demographic Characteristics
25%
Biochemical Parameters
25%
Quality of Life
25%
Dietary Supplements
25%
Between-group Difference
25%
Catabolic
25%
Gastrointestinal Diseases
25%
Cancer Disease
25%
Increased Incidence
25%
Nutritional Intake
25%
Three-level
25%
Immunological Parameters
25%
Fluid Retention
25%
No Significant Difference
25%
Recombinant Human
25%
Opportunistic Infections
25%
IGF-binding protein-3
25%
Fat-free Mass
25%
Clinical Characteristics
25%
Body Mass
25%
Weight Increase
25%
Muscle Measurement
25%
Active Treatment
25%
Body Wasting
25%
Resting Heart Rate
25%
Human Immunodeficiency virus-1 Infection
25%
Muscular Endurance
25%
Endurance Test
25%
Active Placebo
25%
Skinfold Measurements
25%
Peripheral Edema
25%
Isokinetic muscle Strength
25%
Glucoregulation
25%
Treatment Scheme
25%
Medicine and Dentistry
Growth Hormone
100%
Placebo
100%
Human Immunodeficiency Virus Infection
100%
Somatomedin C
100%
Low Drug Dose
100%
Group Therapy
100%
Hormone Therapy
100%
Human Immunodeficiency Virus
75%
Malignant Neoplasm
25%
Protein Binding
25%
Muscle Strength
25%
Human Growth Hormone
25%
Side Effect
25%
Gastrointestinal Disease
25%
Quality of Life
25%
Dietary Intake
25%
Fluid Retention
25%
Human Immunodeficiency Virus 1 Infection
25%
Synapsin II
25%
Skinfold
25%
Opportunistic Infection
25%
Adjuvant
25%
Dietary Supplement
25%
Muscle Exercise
25%
Resting Heart Rate
25%
Peripheral Edema
25%
Pharmacology, Toxicology and Pharmaceutical Science
Growth Hormone
100%
Human Immunodeficiency Virus Infection
100%
Placebo
100%
Somatomedin C
100%
Endocrine Therapy
100%
HIV
75%
Malignant Neoplasm
25%
Side Effect
25%
Binding Protein
25%
Adjuvant
25%
Human Growth Hormone
25%
Gastrointestinal Disease
25%
Dietary Supplement
25%
Synapsin II
25%
Opportunistic Infection
25%
Human Immunodeficiency Virus 1 Infection
25%
Peripheral Edema
25%
Immunology and Microbiology
Human Immunodeficiency Virus Infection
100%
Somatomedin C
100%
Low Drug Dose
100%
Human Immunodeficiency Virus
75%
Protein Binding
25%
Adjuvant
25%
Human Immunodeficiency Virus 1
25%
Body Mass
25%
Muscle Strength
25%
Opportunistic Infection
25%
Fluid Retention
25%
Fat Free Mass
25%
Resting Heart Rate
25%
Muscle Exercise
25%
Skinfold
25%
Agricultural and Biological Sciences
Placebo
100%
Human Immunodeficiency Virus
100%
Bovine Somatotropin
100%
Growth Hormone Treatment
100%
Insulin-Like Growth Factor I
100%
Muscle Strength
25%
Quality of Life
25%
Binding Protein
25%
Skinfold Thickness
25%
Human Immunodeficiency Virus 1
25%
Dietary Supplement
25%
Neuroscience
Human Immunodeficiency Virus
100%
Placebo
100%
Insulin-Like Growth Factor 1
100%
Growth Hormone Treatment
100%
Bovine Somatotropin
100%
Protein Binding
20%
Synapsin II
20%
Human Growth Hormone
20%
Dietary Supplement
20%